Treatment of Otitis Media with Effusion
For a child with otitis media with effusion (OME) without acute infection, the recommended initial approach is watchful waiting for 3 months, with strong recommendations AGAINST using antibiotics, steroids (oral or intranasal), antihistamines, or decongestants 1.
Initial Management: Watchful Waiting
The cornerstone of OME management is observation rather than immediate intervention. Clinicians should manage children with OME who are not at risk with watchful waiting for 3 months from the date of effusion onset (if known) or from diagnosis (if onset is unknown) 1. This approach is based on the favorable natural history of OME, where most cases resolve spontaneously without intervention.
What NOT to Do (Strong Recommendations Against):
The 2016 AAO-HNS guideline provides strong evidence-based recommendations against several common practices 1:
- Do NOT prescribe systemic antibiotics - ineffective for OME treatment
- Do NOT prescribe oral or intranasal steroids - no clinical benefit demonstrated
- Do NOT prescribe antihistamines or decongestants - ineffective for OME
Despite these clear guidelines, national practice data shows these medications are still frequently prescribed inappropriately, representing a significant quality improvement opportunity 2.
Risk Stratification and Monitoring
Identify At-Risk Children
You must determine if the child has increased risk for developmental sequelae 1:
- Baseline sensory deficits (permanent hearing loss, visual impairment)
- Speech/language delays or disorders
- Autism spectrum disorder
- Cognitive/developmental delays
- Craniofacial disorders (cleft palate)
At-risk children require earlier and more aggressive evaluation and intervention 1.
Surveillance Protocol
For children with persistent OME 1:
- Reevaluate at 3- to 6-month intervals until effusion resolves
- Monitor for hearing loss development
- Watch for structural abnormalities of tympanic membrane
When to Obtain Hearing Testing
Obtain age-appropriate hearing evaluation if 1, 3:
- OME persists ≥3 months, OR
- OME of any duration in an at-risk child, OR
- Prior to surgery when child becomes candidate for tympanostomy tubes
This is a recommendation-level statement, emphasizing the importance of documenting hearing impact before surgical intervention.
Surgical Intervention: Tympanostomy Tubes
Indications for Surgery
Offer bilateral tympanostomy tube insertion when 3:
- Bilateral OME persists ≥3 months AND
- Documented hearing difficulties are present
Age-Specific Surgical Recommendations
For children <4 years old 1:
- Recommend tympanostomy tubes when surgery is performed
- Do NOT perform adenoidectomy unless distinct indication exists (nasal obstruction, chronic adenoiditis) separate from OME
For children ≥4 years old 1, 3:
- Recommend tympanostomy tubes, adenoidectomy, or both
- Adenoidectomy may be added to reduce future recurrence or need for repeat tubes 3
Important Surgical Caveats
Do NOT place long-term tubes as initial surgery unless there is anticipated need for prolonged middle ear ventilation beyond that of short-term tubes 3. This represents a new recommendation against routine use of long-term tubes.
Do NOT perform tympanostomy tube insertion for single episode of OME <3 months duration 3.
Postoperative Management
The surgeon must examine the child's ears within 3 months of tube insertion AND educate families about need for routine periodic follow-up until tubes extrude 3. This is a strong recommendation emphasizing the importance of postoperative surveillance.
If acute tube otorrhea develops: prescribe topical antibiotic ear drops ONLY, without oral antibiotics for uncomplicated cases 3.
Patient Education Requirements
Clinicians should educate families regarding 1:
- Natural history of OME (most resolve spontaneously)
- Need for follow-up monitoring
- Possible sequelae, particularly for bilateral OME with hearing loss
- Potential impact on speech and language development when bilateral OME with documented hearing loss exists
Common Pitfalls to Avoid
- Prescribing antibiotics, steroids, or antihistamines/decongestants - despite strong evidence against their use, these remain commonly prescribed 2
- Failing to obtain hearing testing before considering surgery
- Performing adenoidectomy in children <4 years without distinct indication beyond OME
- Inadequate follow-up after tube placement
- Screening asymptomatic, non-at-risk children - not recommended 1